医学
痛风
风湿病
重症监护医学
加药
痹症科
药品
物理疗法
替代医学
临床实习
内科学
药理学
病理
标识
DOI:10.1016/j.rdc.2022.04.003
摘要
The range of drug treatment options to treat acute and chronic gout has changed dramatically over the last 20 years. Yet, there is general consensus that drug therapy selection, dosing and dose titration, of both traditional and novel agents is far from optimally delivered in clinical practice. Updated guidelines disseminated in the last 5 years, from the American College of Physicians, the European League Against Rheumatism, and the American College of Rheumatology, provide clear guidance to the medical community on how and when to optimally integrate these therapeutic options into practice to improve the medical management of gout.
科研通智能强力驱动
Strongly Powered by AbleSci AI